Online weight loss treatment in Illinois
Surfbound connects eligible adults in Illinois with licensed providers for online GLP-1 weight-loss treatment review. Semaglutide $169/mo and tirzepatide $219/mo. Prescriptions are not guaranteed and are issued only when medically appropriate.
No in-person visit. A licensed provider reviews your intake. A prescription is not guaranteed.
Can I start online GLP-1 weight loss treatment in Illinois?
Yes. Eligible adults across Illinois can begin an online GLP-1 weight-loss evaluation with Surfbound without an in-person visit. A licensed provider credentialed in Illinois reviews your health intake and, if treatment is medically appropriate, your prescription may be sent to a licensed pharmacy and shipped discreetly to your Illinois address. Semaglutide is $169/mo and tirzepatide is $219/mo; a prescription is never guaranteed.
The Prairie State · Midwest region. Chicago density versus downstate rural access gaps. Reviewed online by an Illinois-licensed provider, from Chicago to downstate.
Cities in Illinois
Coverage across Illinois
Surfbound lists 6 Illinois cities with a dedicated local page. Care is delivered online, so you can also start from anywhere else in the state.
Provider access & processPricing and insurance
Semaglutide is $169/mo and tirzepatide is $219/mo. Clear pricing shown before checkout. Surfbound does not accept insurance at this time.
Shipping to Illinois
Prescriptions for Illinois patients are routed to a licensed compounding pharmacy. Dispatch follows provider approval, and delivery time varies with distance across the Midwest region, from Chicago, Springfield, Peoria to rural addresses, plus pharmacy and carrier schedules. Tracking is provided by email.
What's included in every Illinois plan
One flat monthly price covers the licensed provider review, medication if prescribed, and discreet shipping. There is no separate membership fee.
Illinois coverage & access
Practical answers about where you can start, how shipping works, and how to compare complete costs in Illinois. The Illinois provider access & process page covers the clinical steps in detail.
Surfbound lists 6 Illinois cities with a dedicated local page. Because care is delivered online, you can start from anywhere in Illinois — the city list is a navigation aid, not a limit on where you can begin.
The Illinois telehealth page explains how the online provider review works, what to prepare before your review, and how prescriptions and provider switches are handled. This coverage page links to it so you have one process reference and one coverage reference.
No. Surfbound is an online service with no physical offices in Illinois. You complete a health intake online, and a licensed provider credentialed in Illinois reviews your information remotely.
Illinois permits telehealth review and prescribing when a proper provider-patient relationship is established, which the online intake and review process does. A provider licensed in Illinois may review an Illinois patient remotely and prescribe only when treatment is medically appropriate. The licensing board, the telehealth statute or rule, and the licensure requirement are listed in the “Telehealth rules in Illinois” section on this page.
Check the two credentials separately. The reviewing clinician must hold an active Illinois license issued by the Illinois Department of Financial and Professional Regulation, and any pharmacy filling your prescription must be licensed in Illinois. Both are public lookups — the board and the telehealth statute or rule that govern them are linked in the “Telehealth rules in Illinois” section on this page.
Compounded semaglutide is $169/mo and compounded tirzepatide is $219/mo for Illinois patients, with the provider review included and no separate membership fee. Pricing is shown before checkout, and compounded medications are not FDA-approved.
If a provider determines treatment is medically appropriate, a prescription may be sent to a licensed compounding pharmacy and medication ships discreetly. Shipping is included; timing depends on pharmacy processing, your location, weekends, and holidays, and tracking is provided.
Not guaranteed anywhere in Illinois. The Illinois-licensed provider can approve, request more information, or decline after reading your intake.
Switching to Surfbound is possible across Illinois. Enter your current medication and dose in the doctor-notes field; the Illinois-licensed provider decides whether to continue at that dose or adjust it, and no written quote is needed.
Use the GLP-1 total-cost calculator to line up total monthly cost for Illinois residents, including fees other programs add on top, against Surfbound's flat price.
Patients in Illinois can be reviewed for compounded semaglutide. The review, the medication if prescribed, and delivery are covered by one published monthly price. Compounded semaglutide is not FDA-approved.
Yes. Compounded tirzepatide — a dual GIP/GLP-1 receptor agonist — is offered across Illinois at a flat monthly rate with no dose-based upcharge. An Illinois-licensed provider determines whether it is medically appropriate, and the pharmacy ships if prescribed. It is not FDA-approved.
Yes. Oral semaglutide and oral tirzepatide are listed options alongside the compounded injectables, and Illinois residents are reviewed the same way for either route. Whether an oral option is appropriate is decided by the Illinois-licensed provider during your review, and oral pricing is shown on those product pages.
No insurer's approval is required to start in Illinois. Surfbound is cash-pay: semaglutide is $169/mo and tirzepatide is $219/mo, the provider review is included, and there is no separate membership fee. Nothing is charged unless a licensed Illinois provider approves your medication. Chicago density versus downstate rural access gaps.
Yes. Illinois residents priced out of a brand-name GLP-1 can be reviewed for compounded semaglutide or tirzepatide. A licensed Illinois provider decides what may be appropriate, and one flat monthly price applies with no dose-based upcharge. Compounded medications are not FDA-approved versions of Wegovy or Zepbound.
Many people across Illinois with PCOS, insulin resistance, or prediabetes explore compounded GLP-1 treatment because brand-name coverage for these uses is often denied. An Illinois-licensed provider reviews your full history to decide whether treatment is medically appropriate. Compounded medications are not FDA-approved.
Yes. Illinois residents complete a short online intake on their own schedule, and an Illinois-licensed provider reviews it remotely. If prescribed, medication ships to your door — no clinic, waiting room, or daytime appointment. Chicago density versus downstate rural access gaps. Reviewed online by an Illinois-licensed provider, from Chicago to downstate.
Yes. Men across Illinois begin with a private online intake, a licensed Illinois provider reviews their history remotely, and if prescribed, medication ships in plain, discreet packaging. There is no waiting room, no in-person visit, and no pharmacy-counter pickup.
Yes. Surfbound support reaches Illinois residents by text/SMS, email (hello@surfbound.co), and phone — new patients at (941) 315-5217 (Monday–Friday, 9:00 AM–5:00 PM ET) and existing patients at (813) 532-3185 (Monday–Friday, 9:00 AM–5:00 PM MST). You can ask about your plan, dosing, or shipping without booking another appointment.
Telehealth rules in Illinois
What governs a provider treating a Illinois patient online, and where you can check it yourself.
State medical board
Illinois Department of Financial and Professional RegulationIllinois Department of Financial and Professional Regulation licenses the providers who review Illinois intakes. The board site carries the current licensing and practice requirements.
Telehealth statute or rule
Illinois Telehealth Act (Public Act 102-0104)Opens the official Illinois code. Search the statute or rule named above for the full text rather than relying on any summary.
Licensure requirement
A clinician must hold an active Illinois license to evaluate or treat a patient who is physically located in Illinois. Every Illinois intake is routed to a provider credentialed in Illinois, and a prescription is issued only when that provider determines treatment is medically appropriate.
Illinois has comprehensive telehealth parity laws. The state does not require an in-person exam prior to telehealth prescribing when a proper medical evaluation has occurred, which Surfbound’s provider review process satisfies.
Surfbound is an online service. We do not have physical offices in Illinois. Licensed providers review health information online. A prescription is not guaranteed.
Medical sources & references
Surfbound providers are licensed to practice in Illinois and follow applicable state medical board rules for telehealth. The following authoritative sources inform our treatment information.
Official Illinois state government agency. Provider licensure in Illinois is governed by the Illinois Department of Financial and Professional Regulation.
- FDA — Human Drug CompoundingFDA guidance clarifying that compounded medications are not FDA-approved.
- FDA — Compounding: Questions and AnswersConfirms compounded drugs are not reviewed by FDA for safety or effectiveness.
- NIDDK (NIH) — Prescription Medications to Treat Overweight & ObesityNIH guidance on GLP-1 receptor agonists for medical weight management.
- CDC — Adult Obesity FactsNational adult obesity prevalence data referenced for regional context.
- ASMBS — American Society for Metabolic and Bariatric SurgeryProfessional guidance on metabolic and bariatric medicine.
- MedlinePlus (NIH) — Weight ControlConsumer health information on weight management from the National Library of Medicine.
A prescription is not guaranteed and is issued only when a licensed provider determines treatment is medically appropriate.